Open-mkt buys · 90d
$11.50M
1 trades · 1 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$11.50M
Insiders on file
12
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Vogelstein R Jacob | Director, 10% Owner | 9 | $0 | $0 | 2026-10-16 |
| Rachlin Evan Lockwood | Director | 9 | $11.50M | $0 | 2026-10-16 |
| Catalio Capital Management, LP | 10% Owner | 8 | $0 | $0 | 2026-10-16 |
| Secora Michael | CFO & Chief Corp Dev Ofcr | 4 | $0 | $0 | 2026-10-16 |
| RASTETTER WILLIAM H | Director, Other | 8 | $0 | $0 | 2026-10-16 |
| Manby Frederick R | Chief Technology Officer, Director | 2 | $0 | $0 | 2026-10-14 |
| Olson Peter A | Chief Scientific Officer | 2 | $0 | $0 | 2026-10-14 |
| Miller Thomas F. | Chief Executive Officer, Director | 2 | $0 | $0 | 2026-10-14 |
| Josephson Neil | Chief Medical Officer | 2 | $0 | $0 | 2026-10-14 |
| Sharp Shalini | Director | 1 | $0 | $0 | 2026-10-14 |
| TAGLIAFERRI MARY | Director | 1 | $0 | $0 | 2026-10-14 |
| EMSTER KURT VON | Director | 1 | $0 | $0 | 2026-10-14 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Vogelstein R Jacob | Director | C Conversion deriv | 2026-10-16 | 2026-10-19 | 742,546 | — | $0 | 0 | SEC↗ |
| Vogelstein R Jacob | Director | C Conversion deriv | 2026-10-16 | 2026-10-19 | 1,458,290 | — | $0 | 0 | SEC↗ |
| Vogelstein R Jacob | Director | C Conversion deriv | 2026-10-16 | 2026-10-19 | 122,684 | — | $0 | 0 | SEC↗ |
| Vogelstein R Jacob | Director | C Conversion deriv | 2026-10-16 | 2026-10-19 | 731,187 | — | $0 | 0 | SEC↗ |
| Vogelstein R Jacob | Director | C Conversion deriv | 2026-10-16 | 2026-10-19 | 1,141,878 | — | $0 | 0 | SEC↗ |
| Vogelstein R Jacob | Director | C Conversion | 2026-10-16 | 2026-10-19 | 742,546 | — | — | 742,546 | SEC↗ |
| Vogelstein R Jacob | Director | C Conversion | 2026-10-16 | 2026-10-19 | 1,458,290 | — | — | 1,458,290 | SEC↗ |
| Vogelstein R Jacob | Director | C Conversion | 2026-10-16 | 2026-10-19 | 1,995,749 | — | — | 1,995,749 | SEC↗ |
| Rachlin Evan Lockwood | Director | C Conversion deriv | 2026-10-16 | 2026-10-19 | 410,762 | — | $0 | 0 | SEC↗ |
| Rachlin Evan Lockwood | Director | C Conversion deriv | 2026-10-16 | 2026-10-19 | 306,711 | — | $0 | 0 | SEC↗ |
| Rachlin Evan Lockwood | Director | C Conversion deriv | 2026-10-16 | 2026-10-19 | 57,754 | — | $0 | 0 | SEC↗ |
| Rachlin Evan Lockwood | Director | C Conversion deriv | 2026-10-16 | 2026-10-19 | 1,152,025 | — | $0 | 0 | SEC↗ |
| Rachlin Evan Lockwood | Director | C Conversion | 2026-10-16 | 2026-10-19 | 57,754 | — | — | 57,754 | SEC↗ |
| Rachlin Evan Lockwood | Director | P Buy | 2026-10-16 | 2026-10-19 | 718,750 | $16.00 | $11.50M | 2,588,248 | SEC↗ |
| Rachlin Evan Lockwood | Director | C Conversion | 2026-10-16 | 2026-10-19 | 410,762 | — | — | 1,869,498 | SEC↗ |
| Rachlin Evan Lockwood | Director | C Conversion | 2026-10-16 | 2026-10-19 | 1,458,736 | — | — | 1,458,736 | SEC↗ |
| Secora Michael | CFO & Chief Corp Dev Ofcr | C Conversion deriv | 2026-10-16 | 2026-10-19 | 61,342 | — | $0 | 0 | SEC↗ |
| Secora Michael | CFO & Chief Corp Dev Ofcr | C Conversion | 2026-10-16 | 2026-10-19 | 61,342 | — | — | 279,902 | SEC↗ |
| RASTETTER WILLIAM H | Director, Other | C Conversion deriv | 2026-10-16 | 2026-10-19 | 8,341 | — | $0 | 0 | SEC↗ |
| RASTETTER WILLIAM H | Director, Other | C Conversion deriv | 2026-10-16 | 2026-10-19 | 14,972 | — | $0 | 0 | SEC↗ |
| RASTETTER WILLIAM H | Director, Other | C Conversion deriv | 2026-10-16 | 2026-10-19 | 36,805 | — | $0 | 0 | SEC↗ |
| RASTETTER WILLIAM H | Director, Other | C Conversion deriv | 2026-10-16 | 2026-10-19 | 64,001 | — | $0 | 0 | SEC↗ |
| RASTETTER WILLIAM H | Director, Other | C Conversion deriv | 2026-10-16 | 2026-10-19 | 76,801 | — | $0 | 0 | SEC↗ |
| RASTETTER WILLIAM H | Director, Other | C Conversion | 2026-10-16 | 2026-10-19 | 8,341 | — | — | 200,920 | SEC↗ |
| RASTETTER WILLIAM H | Director, Other | C Conversion | 2026-10-16 | 2026-10-19 | 192,579 | — | — | 192,579 | SEC↗ |
| Catalio Capital Management, LP | 10% Owner | C Conversion deriv | 2026-10-16 | 2026-10-19 | 742,546 | — | $0 | 0 | SEC↗ |
| Catalio Capital Management, LP | 10% Owner | C Conversion deriv | 2026-10-16 | 2026-10-19 | 1,458,290 | — | $0 | 0 | SEC↗ |
| Catalio Capital Management, LP | 10% Owner | C Conversion deriv | 2026-10-16 | 2026-10-19 | 122,684 | — | $0 | 0 | SEC↗ |
| Catalio Capital Management, LP | 10% Owner | C Conversion deriv | 2026-10-16 | 2026-10-19 | 731,187 | — | $0 | 0 | SEC↗ |
| Catalio Capital Management, LP | 10% Owner | C Conversion deriv | 2026-10-16 | 2026-10-19 | 1,141,878 | — | $0 | 0 | SEC↗ |
| Catalio Capital Management, LP | 10% Owner | C Conversion | 2026-10-16 | 2026-10-19 | 742,546 | — | — | 742,546 | SEC↗ |
| Catalio Capital Management, LP | 10% Owner | C Conversion | 2026-10-16 | 2026-10-19 | 1,458,290 | — | — | 1,458,290 | SEC↗ |
| Catalio Capital Management, LP | 10% Owner | C Conversion | 2026-10-16 | 2026-10-19 | 1,995,749 | — | — | 1,995,749 | SEC↗ |
| Manby Frederick R | Chief Technology Officer, Di | A Award deriv | 2026-10-14 | 2026-10-16 | 793,200 | — | $0 | 793,200 | SEC↗ |
| Manby Frederick R | Chief Technology Officer, Di | A Award | 2026-10-14 | 2026-10-16 | 132,200 | — | $0 | 1,862,665 | SEC↗ |
| Olson Peter A | Chief Scientific Officer | A Award deriv | 2026-10-14 | 2026-10-16 | 116,900 | — | $0 | 116,900 | SEC↗ |
| Olson Peter A | Chief Scientific Officer | A Award | 2026-10-14 | 2026-10-16 | 19,500 | — | $0 | 30,909 | SEC↗ |
| Vogelstein R Jacob | Director, 10% Owner | A Award deriv | 2026-10-14 | 2026-10-16 | 20,300 | — | $0 | 20,300 | SEC↗ |
| Rachlin Evan Lockwood | Director | A Award deriv | 2026-10-14 | 2026-10-16 | 20,300 | — | $0 | 20,300 | SEC↗ |
| Miller Thomas F. | Chief Executive Officer, Dir | A Award deriv | 2026-10-14 | 2026-10-16 | 793,200 | — | $0 | 793,200 | SEC↗ |
| Miller Thomas F. | Chief Executive Officer, Dir | A Award | 2026-10-14 | 2026-10-16 | 132,200 | — | $0 | 1,410,756 | SEC↗ |
| Josephson Neil | Chief Medical Officer | A Award deriv | 2026-10-14 | 2026-10-16 | 185,900 | — | $0 | 185,900 | SEC↗ |
| Josephson Neil | Chief Medical Officer | A Award | 2026-10-14 | 2026-10-16 | 31,000 | — | $0 | 71,459 | SEC↗ |
| Secora Michael | CFO & Chief Corp Dev Ofcr | A Award deriv | 2026-10-14 | 2026-10-16 | 170,300 | — | $0 | 170,300 | SEC↗ |
| Secora Michael | CFO & Chief Corp Dev Ofcr | A Award | 2026-10-14 | 2026-10-16 | 28,400 | — | $0 | 218,560 | SEC↗ |
| Sharp Shalini | Director | A Award deriv | 2026-10-14 | 2026-10-16 | 20,300 | — | $0 | 20,300 | SEC↗ |
| TAGLIAFERRI MARY | Director | A Award deriv | 2026-10-14 | 2026-10-16 | 20,300 | — | $0 | 20,300 | SEC↗ |
| RASTETTER WILLIAM H | Director, Other | A Award deriv | 2026-10-14 | 2026-10-16 | 40,600 | — | $0 | 40,600 | SEC↗ |
| EMSTER KURT VON | Director | A Award deriv | 2026-10-14 | 2026-10-16 | 20,300 | — | $0 | 20,300 | SEC↗ |